|
FAM65A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.918390E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.611770E-01 |
| Normal-vs-Stage2 |
4.090200E-02 |
| Normal-vs-Stage3 |
4.040400E-03 |
| Normal-vs-Stage4 |
4.594200E-04 |
| Stage1-vs-Stage2 |
1.663170E-01 |
| Stage1-vs-Stage3 |
5.202300E-03 |
| Stage1-vs-Stage4 |
3.017100E-04 |
| Stage2-vs-Stage3 |
5.559800E-01 |
| Stage2-vs-Stage4 |
1.746620E-01 |
| Stage3-vs-Stage4 |
2.524600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.663840E-02 |
| Normal-vs-AfricanAmerican |
6.783800E-02 |
| Normal-vs-Asian |
9.091400E-01 |
| Caucasian-vs-AfricanAmerican |
8.375600E-01 |
| Caucasian-vs-Asian |
2.911200E-01 |
| AfricanAmerican-vs-Asian |
3.780200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.482200E-03 |
| Normal-vs-Female |
2.073200E-01 |
| Male-vs-Female |
1.260600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.924420E-01 |
| Normal-vs-Age(41-60Yrs) |
1.283370E-01 |
| Normal-vs-Age(61-80Yrs) |
3.156600E-03 |
| Normal-vs-Age(81-100Yrs) |
1.200410E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.319400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.923800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.642600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.503700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.027000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.424000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.618300E-02 |
| Normal-vs-Grade 2 |
9.904300E-02 |
| Normal-vs-Grade 3 |
4.700200E-03 |
| Normal-vs-Grade 4 |
4.207700E-04 |
| Grade 1-vs-Grade 2 |
4.13049999999915E-05 |
| Grade 1-vs-Grade 3 |
2.22679999994924E-08 |
| Grade 1-vs-Grade 4 |
2.81840000226907E-08 |
| Grade 2-vs-Grade 3 |
1.556010E-02 |
| Grade 2-vs-Grade 4 |
1.504860E-03 |
| Grade 3-vs-Grade 4 |
9.464400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.506800E-01 |
| Normal-vs-ccB subtype |
7.172400E-04 |
| ccA subtype-vs-ccB subtype |
1.66810000035156E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.354240E-02 |
| Normal-vs-N1 |
2.153400E-01 |
| N0-vs-N1 |
9.273200E-01 |
|
|
